Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue

Clinical Trial ID NCT00908791

PubWeight™ 1.94‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00908791

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies. Adv Nutr 2011 1.18
2 A proof of principle clinical trial to determine whether conjugated linoleic acid modulates the lipogenic pathway in human breast cancer tissue. Breast Cancer Res Treat 2013 0.81
Next 100